Seven ranked. Thirteen worth noting. Eight editions a day. Read in three minutes. Forwarded in under one.
Also worth noting
M&A Padres sold to Chelsea owner for $3.9B. Sports franchises now price like growth tech. The multiple keeps expanding.
M&A Orchestra PE exited KFC Korea at $135M. Carlyle took the risk. Three-year hold, clean exit. Disciplined.
Earnings Private credit funds faced $20B in redemption requests. Liquidity stories are becoming credit stories. Watch the next earnings call carefully.
Funding East Bay startup targeting $1B IPO valuation this week. Pre-revenue, Series D extended. The market will correct this.
Trend Space stocks rallied on SpaceX IPO speculation. The market is pricing the future, not the news. When the IPO actually files, re-anchor your thesis.
Funding Pasqal SPAC merger moving forward. Quantum computing is two markets: the reality and the story. Investors are still buying the story.
Earnings Willis Towers Watson 10-K filing reveals margin compression. Consulting holding companies can't hide operational fatigue anymore.
Earnings Biogen financials due. Biotech is split: approved drugs printing, pipeline priced like it doesn't exist. Watch the guidance.
Trend Cars.com 8-K filing expected. Automotive retail is still fighting logistics. The comps haven't moved in three years.
Trend Form 8-K material events continue across industrials. Restructurings are quiet. The headlines arrive in Q4.
Trend US IPO weekly winners include biotech plays. The high-growth cohort is pricing harder than it deserves. The medium-growth cohort is being left behind.
M&A Strive's Semler acquisition signals digital asset treasury consolidation. The next wave of M&A is infrastructure. Horizontal synergies won't appear until 2026.
Trend Renaissance Capital tracking IPO momentum. Pre-revenue biotech is repricing. The floor under early-stage valuations just moved up 25%.